Physician profile
Simon Moradian
NPI 1124412291
$5,023.87
in general payments reported to CMS, 2019-2025
16 companies · $1,535 in 2025
The $1,535 reported for 2025 was more than what 79% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2022: $331 · 2023: $168 · 2024: $2,858 · 2025: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345 · Travel and Lodging: $2,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,345.19 |
| Travel and Lodging | $2,215.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,270.63 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $755.17 | 2025 | |
| Acera Surgical, INC. | $326.17 | 2024 | Restrata Wound Matrix |
| Avita Medical Americas, LLC | $284.21 | 2024-2025 | Permeaderm, Recell, Cohealyx |
| Allergan, INC. | $273.27 | 2019-2022 | |
| Microaire Surgical Instruments LLC | $207.92 | 2025 | |
| Integra Lifesciences Corporation | $190.03 | 2022 | |
| Motiva USA, LLC | $187.02 | 2024-2025 | |
| Innovation Technologies INC | $167.57 | 2023 | Irrisept |
| Rti Surgical, INC | $154.93 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $52.12 | 2025 | Exparel |
| Ethicon US, LLC | $39.84 | 2025 | Stratafix |
| W. L. Gore & Associates, INC. | $36.86 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Davol INC. | $36.23 | 2024 | Arista Ah Flexitip |
| Mentor Worldwide LLC | $27.94 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $13.96 | 2025 | Insorb |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Moradian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.